Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salah Ferkal

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Orphanet Journal of Rare Diseases|September 5, 2012
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional studyEmilie Sbidian, Smaïl Hadj-Rabia, Vincent M Riccardi, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohortMartin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
The Journal of Investigative Dermatology|April 30, 2010
NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1Emilie Sbidian, Pierre Wolkenstein, Laurence Valeyrie-Allanore, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
The Journal of Investigative Dermatology|February 18, 2024
Whole-Body Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1Laura Fertitta, Arnaud Jannic, Ouidad Zehou, et al.
Arthritis Care & Research|March 26, 2014
Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohortFlorence Canouï-Poitrine, Cécile Poulain, Anna Molto, et al.
Orphanet Journal of Rare Diseases|May 6, 2011
Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in FranceTu Anh Duong, Emilie Sbidian, Laurence Valeyrie-Allanore, et al.
The British Journal of Dermatology|November 25, 2025
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-DLaura Fertitta, Kavita Y Sarin, Carlos G Romo, et al.
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Orphanet Journal of Rare Diseases|September 5, 2012
Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional studyEmilie Sbidian, Smaïl Hadj-Rabia, Vincent M Riccardi, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohortMartin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
The Journal of Investigative Dermatology|April 30, 2010
NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1Emilie Sbidian, Pierre Wolkenstein, Laurence Valeyrie-Allanore, et al.
Human Mutation|August 6, 2013
NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experienceAudrey Sabbagh, Eric Pasmant, Apolline Imbard, et al.
The Journal of Investigative Dermatology|February 18, 2024
Whole-Body Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1Laura Fertitta, Arnaud Jannic, Ouidad Zehou, et al.
Arthritis Care & Research|March 26, 2014
Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohortFlorence Canouï-Poitrine, Cécile Poulain, Anna Molto, et al.
Orphanet Journal of Rare Diseases|May 6, 2011
Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in FranceTu Anh Duong, Emilie Sbidian, Laurence Valeyrie-Allanore, et al.
The British Journal of Dermatology|November 25, 2025
Stigmatization related to cutaneous neurofibromas in neurofibromatosis 1: Development, validation and severity strata of the cNF-PUSH-DLaura Fertitta, Kavita Y Sarin, Carlos G Romo, et al.
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Pageof 3